Subscribe to Pharma
View Sample

FREE Email Newsletter

Gene Therapy Protects Against Pandemic Flu Strains

May 30, 2013 11:21 am | News | Comments

Researchers have developed a new gene therapy to thwart a potential influenza pandemic. Investigators demonstrated that a single dose of an adeno-associated virus (AAV) expressing a broadly neutralizing flu antibody into the nasal passages of mice and ferrets gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus.

Nanoparticles Shape-shift in Response to Tumor Signal

May 29, 2013 11:28 am | News | Comments

Scientists have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer.

Liquid-repelling Paper May Yield New Biomedical Diagnostics

May 29, 2013 10:35 am | News | Comments

Paper is known for its ability to absorb liquids, making it ideal for products such as paper towels. But by modifying the underlying network of cellulose fibers, etching off surface “fluff” and applying a thin chemical coating, researchers have created a new type of paper that repels a wide variety of liquids– including water and oil.


Lab-based Skin Test Predicts Adverse Drug Reactions

May 28, 2013 11:46 am | News | Comments

A simple lab-based skin test which eliminates the risk of adverse reactions to new drugs, cosmetics and household chemicals has been developed by team of researchers. It uses real human skin and immune cells to show any reaction such as a rash or blistering indicating a wider immune response within the body. 

Protein Fusion May Yield Universal Influenza Vaccination

May 23, 2013 11:47 am | News | Comments

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept represents an important step forward in the quest to develop a universal influenza vaccine.

Addiction-blocking Drug Under Development

May 22, 2013 12:50 pm | News | Comments

Researchers have unraveled the molecular foundations of cocaine’s effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing further animal testing in preparation for possible clinical trials in cocaine addicts.

Researchers Closer to Alzheimer's Prevention, Treatment

May 22, 2013 11:10 am | News | Comments

Imagine a pharmaceutical prevention, treatment or even cure for Alzheimer’s disease. It is almost impossible to overstate how monumental a development that would be and how it would answer the prayers of millions. Though science isn’t there yet, a new study offers a tantalizing glimpse of potential solutions.

One-step Genetic Engineering Technology Developed

May 22, 2013 10:06 am | News | Comments

A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting. The method paves the way for more rapid development of designer microbes for drug development, environmental cleanup and other activities.


Vitamin C Kills Drug-resistant TB

May 21, 2013 12:00 pm | by Einstein | News | Comments

Researchers have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design.

A New Way to Open Clogged Arteries

May 21, 2013 11:03 am | News | Comments

Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments has drawbacks, including the risk of side effects.

UK Measles Surge Years After Vaccine Scare

May 20, 2013 6:00 am | by MARIA CHENG - AP Medical Writer - Associated Press | News | Comments

More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease. This year, the U.K. has had more than 1,200 cases of measles, after a record number of nearly 2,000 cases last year.

WHO says single yellow fever shot is enough

May 17, 2013 3:55 am | by The Associated Press | News | Comments

The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary. The U.N.'s global health agency said Friday that its expert group on immunization believes a single dose of vaccination is sufficient to confer lifelong immunity against the disease.

Nanogel Secretes Insulin on Demand

May 16, 2013 11:49 am | News | Comments

Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles were designed to sense glucose levels in the body and respond by secreting the appropriate amount of insulin, thereby replacing the function of pancreatic islet cells, which are destroyed in patients with Type 1 diabetes.


New Drug Slows Alzheimer's

May 15, 2013 10:17 am | News | Comments

A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings may pave the way to a new treatment for Alzheimer's disease in humans.

India to Offer $1 Rotavirus Vaccine

May 14, 2013 7:43 am | by The Associated Press | News | Comments

The Indian government announced the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world. The Indian manufacturer of the new rotavirus vaccine pledged to sell it for $1 a dose, a significant discount from the cost of the current vaccines on the market.

Medicinal Plant Can Treat Anxiety

May 13, 2013 10:17 am | News | Comments

A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety. The study revealed Kava could be an alternative treatment to pharmaceutical products for those who suffer from Generalized Anxiety Disorders (GAD).

Study Reveals How Nerve Axons Self-destruct

May 10, 2013 10:29 am | News | Comments

Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other parts of the body, allowing movement, sight and sense of touch, among other vital functions.

Antibody a Possible Blood Cancer Treatment

May 6, 2013 4:10 pm | News | Comments

A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. Using a "biological library" of thousands of antibodies, researchers singled out antibody BI-505, shown to have a powerful effect on the tumor cells.

More Vitamin D May Not Be Better

May 2, 2013 11:33 am | News | Comments

In recent years, healthy people have been bombarded by stories in the media and on health websites warning about the dangers of too-low vitamin D levels, and urging high doses of supplements to protect against everything from hypertension to hardening of the arteries to diabetes.

Physical by Smartphone a Growing Possibility

May 2, 2013 12:20 am | by LAURAN NEERGAARD - AP MEDICAL WRITER | News | Comments

It's not a "Star Trek" tricorder, but by hooking a variety of gadgets onto a smartphone you could almost get a complete physical- without the paper gown or even a visit to the doctor's office. Blood pressure? Just plug the arm cuff into the phone for a quick reading.

SARS Treatment Works on Novel Coronoavirus

May 1, 2013 9:27 am | News | Comments

Scientists used lab-grown human lung cells to study the cells’ response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted in early and late stages of infection.

Toxic, Foul-smelling Gas Reduces Arthritis Swelling

April 30, 2013 11:59 am | News | Comments

A gas associated with the smell of rotten eggs has proven to effectively reduce joint swelling, in research which could lead to advances in the treatment of arthritis. Scientists have discovered that a novel drug molecule, which slowly generates the gas hydrogen sulfide (H2S), effectively reduces swelling and inflammation in arthritic joints.

Cancer Cell Mapping May Yield New Drugs

April 29, 2013 12:13 pm | News | Comments

For the first time, researchers have managed to obtain detailed images of the way in which the transport protein GLUT transports sugars into cells. Since tumours are highly dependent on the transportation of nutrients in order to be able to grow rapidly, the researchers are hoping that the study will form the basis for new strategies to fight cancer cells.

New Antibodies Help Fight Stubborn Bacteria

April 25, 2013 12:03 pm | News | Comments

In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of selective antimicrobial agents that do not rely on traditional antibiotics.

Coffee, with Pill, Reduces Breast Cancer Recurrence

April 25, 2013 11:03 am | News | Comments

Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.